Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
(NasdaqGM:TVGN),(NASDAQ:TVGNW), WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP Partners and The Patel Family LLP, investors in innovative healthcare ventures, congratulated Tevogen Bio and Dr. Ryan Saadi for their efforts to […]